Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital Admission

NCT07756554 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9000

Last updated 2026-08-10

No results posted yet for this study

Summary

This multicenter, cluster-randomized, unblinded quality-improvement study evaluates whether home-based clinical assessment by municipal acute care teams can safely reduce hospital admissions among nursing home residents experiencing acute illness or clinical deterioration during out-of-hours periods. Participating nursing homes in the Capital Region of Denmark will be randomized to either usual care (contacting the regional medical helpline, 1813) or the intervention pathway, in which nursing home staff contact a municipal acute care team directly. The acute care team performs an on-site clinical assessment and, when needed, consults a senior physician in the hospital emergency department to establish a treatment and observation plan, which may include continued management at the nursing home under hospital responsibility. The study compares the intervention with usual care with respect to hospital admissions and mortality among nursing home residents.

Conditions

Interventions

OTHER

Home-based Clinical Assessment and Treatment

Nursing homes in the intervention group will, if a resident experiences acute illness or clinical deterioration, call the municipal acute care team directly. They will then do a home-based clinical assessment and, if deemed necessary, consult a senior physician in the hospital emergency or geriatrics department to establish a treatment and observation plan.

Sponsors & Collaborators

  • Herlev and Gentofte Hospital

    collaborator OTHER
  • Amager Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • Nordsjaellands Hospital

    collaborator OTHER
  • Copenhagen University Hospital at Herlev

    lead OTHER

Principal Investigators

  • Kasper K Iversen, MD, Professor · University Hospital of Copenhagen Herlev and Gentofte

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-01
Primary Completion
2027-06-30
Completion
2027-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07756554 on ClinicalTrials.gov